During the past decade, Hospital Privado Centro Medico de Cordoba conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 37 clinical trials were completed, i.e. on average, 63.8% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 27 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Privado Centro Medico de Cordoba" #1 sponsor was "Janssen Research & Development, LLC" with 15 trials, followed by "Pfizer" with 5 trials sponsored, "Shire" with 5 trials sponsored, "Actelion" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Privado Centro Medico de Cordoba" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Innogene Kalbiotech Pte. Ltd" with 2 trials as a collaborator, "Laboratorio Elea Phoenix S.A." with 2 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Privado Centro Medico de Cordoba" are "Pulmonary Arterial Hypertension" (6 trials), "Crohn Disease" (5 trials), "Ulcerative Colitis" (5 trials), "Pulmonary Hypertension" (4 trials) and "Rheumatoid Arthritis" (4 trials). Many other conditions were trialed in "Hospital Privado Centro Medico de Cordoba" in a lesser frequency.

Most popular intervention types in "Hospital Privado Centro Medico de Cordoba" are "Drug" (69 trials), "Other" (16 trials), "Biological" (8 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Ontamalimab" (4 trials), "Prednisone" (4 trials), "Dexamethasone" (3 trials) and "Empagliflozin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Privado Centro Medico de Cordoba" are 77 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Privado Centro Medico de Cordoba". undefined are not yet recruiting, 17 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in Hospital Privado Centro Medico de Cordoba, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Privado Centro Medico de Cordoba, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".

Hospital Privado Centro Medico de Cordoba has several departments that took part in Clinical trials: "HOSPITAL PRIVADO - CENTRO MEDICO DE CÓRDOBA; Dpto Oncología" - 3 trials